CEA, Fluid
Test Mnemonic
CEAFL
CPT Codes
- 82378 - QTY (1)
Aliases
- Carcinoembryonic Antigen, Fluid
- FCEA
Performing Laboratory
ARUP
FDA Category
Laboratory Developed Test
Specimen Requirements
| Volume | Type | Container | Collect Temperature | Transport Temperature | Special Instructions |
|---|---|---|---|---|---|
| 1 mL | Cerebrospinal fluid (CSF) | Clean container | Refrigerated | Centrifuge to remove cellular material. |
Alternate Specimen Requirements
| Volume | Type | Container | Collect Temperature | Transport Temperature | Special Instructions |
|---|---|---|---|---|---|
| 1 mL | Fluid, pancreatic | Clean container | Refrigerated | Centrifuge to remove cellular material. | |
| 1 mL | Fluid, pericardial | Clean container | Refrigerated | Centrifuge to remove cellular material. | |
| 1 mL | Fluid, peritoneal | Clean container | Refrigerated | Centrifuge to remove cellular material. | |
| 1 mL | Fluid, pleural | Clean container | Refrigerated | Centrifuge to remove cellular material. |
Minimum Specimen Requirements
| Volume | Type | Container | Collect Temperature | Transport Temperature | Special Instructions |
|---|---|---|---|---|---|
| 0.5 mL |
Stability
| Environmental Condition | Description |
|---|---|
| Ambient | 8 hours |
| Refrigerated | 7 days |
| Frozen | 6 months |
Days Performed
Sun - Sat
Turnaround Time
2 - 3 days
Methodology
| Name | Description |
|---|---|
| Electro Chemiluminescence Immunoassay (ECLIA) |
Reference Range
| CEA, Fluid | |||||
|---|---|---|---|---|---|
| Sex | Age From | Age To | Type | Range | Range Unit |
| Refer to http://aruplab.com/bodyfluids/ |
Special Info
Specify fluid type on requisition.
Clinical Info
The Roche CEA electrochemiluminescent immunoassay is used. Results obtained with different assay methods or kits cannot be used interchangeably. Measurements of CEA have been shown to be clinically relevant in the management of patients with colorectal, breast, lung, prostatic, pancreatic, and ovarian carcinomas. Smokers may have slightly elevated levels of CEA. The CEA assay value, regardless of level, should not be interpreted as evidence for the presence or absence of malignant disease and is not recommended for use as a screening procedure to detect the presence of cancer in the general population.